INAB Stock Analysis: Buy, Sell, or Hold?
INAB - IN8bio, Inc. Common Stock
$1.99
0.03 (1.53%)
▲
5d:
-3.86%
30d:
-19.11%
90d:
+2.05%
BUY
HIGH Confidence
Last Updated: February 3, 2026
Earnings: Mar 12, 2026
Get Alerted When INAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INAB shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: INAB shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: INAB is currently trading at $1.99, which is considered oversold relative to its 30-day fair value range of $2.07 to $2.45.
Technical Outlook: Technically, INAB is showing sideways momentum. Immediate support is located at $1.87, while resistance sits at $2.54.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.50 (+528.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INAB is showing sideways momentum. Immediate support is located at $1.87, while resistance sits at $2.54.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.50 (+528.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.07 -
$2.45
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 528.1% below Wall St target ($12.50)
Fair Price Analysis
30-Day Fair Range
$2.07 -
$2.45
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.87
Resistance Level
$2.54
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-0.81
Wall Street Target
$12.50
(+528.1%)
Last updated: February 03, 2026 6:42 PM ET
Data refreshes hourly during market hours. Next update: 7:42 PM
Data refreshes hourly during market hours. Next update: 7:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 58 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$277 | 60 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 60 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$39 | 59 HOLD |
